Current position

Ray Dalio’s Cognex Corp (CGNX) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Bridgewater Associates, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ4 2019Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares98.95KHighest verified quarter-end share count
Quarters reported10Verified quarters with shares above zero
What happened?

Bridgewater Associates, LP first reported Cognex Corp in Q4 2019. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Bridgewater Associates, LP currently reports 4.96K shares. The latest verified filing showed: Sold 94.1% of the position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Sold 94.1% of the position−78.61K shares · 4.96K shares remained
Filing context

Quarter-end price $72.42 · Estimated holding basis $48.99

Q1 2026
New position+83.57K shares · 83.57K shares reported
Filing context

Quarter-end price $48.99 · Estimated holding basis $48.99

Q4 2022
Sold the entire position−69.13K shares · No shares reported at quarter-end
Q3 2022
Bought 85.0% more+31.77K shares · 69.13K shares reported after the change
Filing context

Quarter-end price $41.44 · Estimated holding basis $60.74

Q2 2022
Sold 62.2% of the position−61.59K shares · 37.36K shares remained
Filing context

Quarter-end price $42.53 · Estimated holding basis $77.15

Q1 2022
New position+98.95K shares · 98.95K shares reported
Filing context

Quarter-end price $77.15 · Estimated holding basis $77.15

Portfolio importance

How important is Cognex Corp in Bridgewater Associates, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.0%Q2 2026
Current rank#957of 997 reported positions
Peak portfolio weight0.0%Q2 2021
Best historical rank#325Q4 2020
At peak importanceQ2 2021
CGNX
0.0%
Largest holding
5.4%
Cross-investor discovery

Who else owns Cognex Corp?

Also reported by 1 other tracked investor in their latest verified filings.

Joel GreenblattGotham Asset Management
CGNX0.1% of reported portfolio
Explore Cognex Corp across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$59.902026-09-14

Market context only; not an investor transaction price.

Latest filing quarter-end price$72.42Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$48.99Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Bridgewater Associates, LP’s Form 13F disclosures, not Ray Dalio’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.